A team of researchers led by bioengineer Shaochen Chen will use 3D printing techniques to shape stem cells produced by local firm Allele Biotechnology ...
The FDA has issued a second complete response letter to Atara Biotherapeutics for its biologicals license application of ...
The agency is asking the firm to conduct a new study, which Pierre Fabre says is "a significant and unexpected change" from prior discussions.
Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular ...
InvestorsHub on MSN
Atara Biotherapeutics shares sink after FDA issues rejection letter
Shares of Atara Biotherapeutics (NASDAQ:ATRA) plunged about 55% on Monday after the U.S. Food and Drug Administration ...
The U.S. Food and Drug Administration on Monday declined to approve Atara Biotherapeutics' cell therapy for a rare form of ...
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles ...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer ...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...
The FDA declined to approve EBVALLO (tabelecleucel), Atara’s treatment for Epstein-Barr virus positive post-transplant ...
SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease ...
Apple breeding focuses on unique traits like red flesh, but success depends on genetic compatibility. This study refined a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback